Cosmetic matrikine peptide

Syn-Coll

Syn-Coll is the trade name of a cosmetic ingredient, palmitoyl tripeptide-5; the app lists a 4-hour half-life, a figure none of the retrieved sources reports.1

Limited evidence (the app's grade, not a conclusion of the sources)Get the app

Level after one dose

Syn-Coll after one dose: 50% at ~4 h, 25% at 8 h, 12.5% at 12 h.

Drawn from the half-life in the app's model, ~4 h. The model's figures

Syn-Coll is a Pentapharm trade name whose INCI name is palmitoyl tripeptide-5, and the manufacturer's data sheet describes the product as "an aqueous, unpreserved, glycerine-based solution of a small peptide".1 The chemical name on the sheet is palmitoyl-lysyl-valyl-lysine bistrifluoracetate salt, and a 2025 review gives the sequence as Lys-Val-Lys.1,3 A 2021 review by Resende and colleagues (Pharmaceuticals) calls palmitoyl tripeptide-5 "a fragment of Thrombospondin I (TSP-1)".2 The app places it among tanning-category compounds as a cosmetic matrikine peptide, grades the evidence as limited, and lists topical use only.1

The manufacturer's sheet states that thrombospondin I is a "protein that activates the latent but biologically inactive form of TGF-β", and that Syn-Coll has a "unique sequence to mimic the human body’s own mechanism to produce collagen via".1 The sheet says the product "stimulates the collagen synthesis in human fibroblasts" and gives no data, method or skin measurement for this statement.1 Pintea and colleagues (Biomolecules, 2025) list it among signal peptides, with the role "Boosts collagen production by stimulating TGF-β production and increasing cellular communication".3 Resende and colleagues add that it is used in anti-aging cosmetic products, and that "neither efficacy studies for the use of palmitoyl tripeptide-5 alone or in this mix in rosacea of sensitive skin are available".2

3

Half-life and pharmacokinetics

Values from the Milligram app's model.

Half-life
~4 h
Bioavailability
95%
Typical dose
2–5 %
Route
Topical
Time to peak
~0.5 h

Sources in this part

  1. 3Pintea et al., 2025

The second column holds the app's figures, shown beside what the retrieved sources report.

Table 3.1Half-life and pharmacokinetics3 rows
ParameterApp's figureReported in the sources
Half-life~4 hNo figure in the sources retrieved
Bioavailability95%No figure in the sources retrieved
Time to peak~0.5 hNo figure in the sources retrieved

The app's own note states that it is a topical ingredient with negligible systemic absorption and that its modelled curve does not reflect how it works, so the 4-hour half-life and 95% bioavailability are model inputs, not measurements reported by the sources. Pintea and colleagues note a general difficulty for cosmetic peptides: "most oligopeptides with high molecular weight and low lipophilicity are described as poor in osmosis", a statement about oligopeptides in general and not a measurement for palmitoyl tripeptide-5.3

4

Human studies

No controlled trial in people of Syn-Coll or palmitoyl tripeptide-5 appears among the 4 PubMed records and 2 ClinicalTrials.gov studies returned by the searches, although one PubMed record, a 2020 trial of mixed peptides on hyaluronic acid microneedle patches, was not read, and neither ClinicalTrials.gov study names the compound in its title. The only human data retrieved sit in the manufacturer's own data sheet, which gives no authors, journal, date or peer review.1

Table 4.1Human studies1 row
Study and yearDesignPeopleDose and lengthMain result
Manufacturer data sheet, Pentapharm, undated1Compared with placebo and with a reference substance; blinding and randomisation not stated160 volunteers12.5% Syn-Coll (25 ppm peptide) applied twice daily for 84 days; reference palmitoyl pentapeptide at 10 ppm1Average relief (Rz) and maximum relief (Rt) decreased by -12%: -22 µm and -36 µm (p= 0.05) with Syn-Coll; the sheet states Syn-Coll "clearly showed a higher efficacy" than the reference1

Sources in this part

  1. 1Pentapharm Ltd

Deeper analysis: the manufacturer's 84-day wrinkle study

The study is described only in Pentapharm's technical data sheet, so it is a manufacturer report and not a journal article; the sheet names no investigators and no funder other than the company's own document.1 The sheet says it "has been compared against placebo and against a reference substance", with "twice- daily application" over 84 days, and measured skin relief with the PRIMOS technique, which projects stripe patterns and analyses their deformation.1 After 84 days of 2.5% Syn-Coll, Rz and Rt "significantly decreased by -12%: -22 µm and -36 µm respectively (p= 0.05)", which the sheet describes as "smoothing and anti wrinkle effects".1 The sheet does not give the result for the placebo group, the group sizes, confidence intervals, the vehicle, the sites measured or any adverse events from the study.1 In a volunteer questionnaire the sheet reports "93 % of the volunteers will continue the use of a SYN®-COLL" containing formula, a statement of intent and not a skin measurement.1 On safety, the sheet states that safety testing "proved the product to be safe for cosmetic use", with no test results shown.1

5

Doses reported in studies and on labels

Sources in this part

  1. 1Pentapharm Ltd
Table 5.1Doses reported in studies and on labels3 rows
SourceContextConcentration reported
Manufacturer data sheet1Wrinkle study, 60 volunteers, twice daily for 84 days2.5% Syn-Coll, equal to 25 ppm peptide1
Manufacturer data sheet1Addition level the sheet gives for skin care preparations1 to 3% Syn-Coll1
The appTypical dose2–5 %, which reaches higher than the sheet's 1 to 3%1
6

Side effects reported

Sources in this part

  1. 1Pentapharm Ltd

No adverse event rate for palmitoyl tripeptide-5 is reported in the retrieved sources; the manufacturer's sheet states only that safety testing "proved the product to be safe for cosmetic use".1

7

Regulatory and anti-doping status

The text of the World Anti-Doping Agency 2026 Prohibited List retrieved for this work contains no entry naming palmitoyl tripeptide-5 or Syn-Coll.4 Several entries of the list end with the wording "and other substances with a similar chemical structure or similar biological effect(s)", and whether a topical cosmetic peptide falls under any such entry is not addressed in the sources.4 No drug regulator's document on palmitoyl tripeptide-5 was identified in the sources retrieved.

8

Storage and handling

Sources in this part

  1. 1Pentapharm Ltd

The manufacturer's sheet gives storage in the original sealed container, protected from light, at a temperature between 15 and 25°C, and "remains stable for at least 1 year" under those conditions.1 It contains no preservative, and the sheet gives a stable pH range of 3.0 to 7.0.1

9

What is not known

Sources in this part

  1. 1Pentapharm Ltd

No independent, peer-reviewed human study of Syn-Coll appears among the records screened, one PubMed record was not read, and the one human dataset retrieved is the manufacturer's own.1 None of the retrieved sources gives skin penetration, blood levels, a half-life or a time to peak for the compound, so the app's pharmacokinetic figures cannot be checked against a source.1 Whether the wrinkle changes reported on the sheet would hold in an independent, blinded study with the placebo group's result shown is not known from the sources.1

10

Frequently asked questions

What is Syn-Coll?

Syn-Coll is a Pentapharm trade name for a cosmetic ingredient whose INCI name is palmitoyl tripeptide-5.1

What is the half-life of Syn-Coll?

The app lists a half-life of about 4 hours, and none of the sources retrieved reports a half-life for the compound.1

What is the bioavailability of Syn-Coll?

The app lists 95%, and none of the sources retrieved gives a bioavailability figure for it.1

Is Syn-Coll banned by WADA?

The 2026 Prohibited List text retrieved contains no entry naming palmitoyl tripeptide-5 or Syn-Coll.4

Has Syn-Coll been tested in people?

The manufacturer's data sheet reports a 60-volunteer, 84-day study, and no independent controlled trial appears among the PubMed and ClinicalTrials.gov records returned, one PubMed record having not been read.1

What is the amino acid sequence of palmitoyl tripeptide-5?

A 2025 review gives the sequence as Lys-Val-Lys.3

What does Syn-Coll mimic?

The manufacturer states that it has a "unique sequence to mimic the human body’s own mechanism to produce collagen via" TGF-β.1

What concentration does the manufacturer give for Syn-Coll?

The sheet gives an addition of 1 to 3% for skin care preparations, and its wrinkle study used 2.5%, while the app lists 2–5 %.1

12

References

  1. Pentapharm Ltd. SYN-COLL technical data sheet (undated), hosted as a PDF by a retailer. Pentapharm data sheet
  2. Resende DISP, et al. Usage of Synthetic Peptides in Cosmetics for Sensitive Skin. Pharmaceuticals 2021. PMID 34451799
  3. Pintea A, et al. Peptides: Emerging Candidates for the Prevention and Treatment of Skin Senescence: A Review. Biomolecules 2025. PMID 39858482
  4. World Anti-Doping Agency. World Anti-Doping Code International Standard: Prohibited List 2026. WADA list